18 Hrs
المصدر:
USA TODAY
USA TODAY
جاهز للتشغيل
جاهز للتشغيل
Experimental peptides are gaining popularity among influencers and some health advocates despite lacking FDA approval for safety or efficacy. Although a recent White House proposal would increase access to unapproved peptides, scientific experts warn that many claims about their safety and therapeutic benefits are misleading, given the limited clinical research. The article emphasizes that peptides are drugs when used to treat or influence the body, contradicting common myths that they are natural or inherently safe, and highlights concerns about insufficient testing and potential risks.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading